Risk factors

Pricing pressures and reimbursement controls in the U.S. and EU threaten profit margins across key pharmaceutical portfolios. Heavy reliance on major branded drugs like Eliquis, Opdivo, Orencia, and Yervoy creates revenue concentration risk. Extensive debt from large acquisitions including Celgene, MyoKardia, Mirati, Karuna, and RayzeBio impacts financial flexibility.

The risk factors are dominated by commercial real estate debt exposure, interest rate volatility, loan defaults, and liquidity constraints.

CareTrust REIT is a healthcare real estate investment trust heavily dependent on government reimbursement rates for tenants operating skilled nursing facilities.

CVS Health faces intense regulatory scrutiny regarding Medicare rates, drug pricing benchmarks, and health care policy reform. The company manages major integration risks from expanding into value-based care through Signify Health and Oak Street Health. Cybersecurity, data governance, and information technology failures present significant ongoing threats to operations and reputation.

DHI Group faces concentration risks in its tech-focused strategy, brand reliance on Dice and ClearanceJobs, and debt obligations under a credit agreement.

Eastgroup Properties is dominated by real estate market conditions and industrial property leasing risks. Local economic downturns, tenant bankruptcies, and supply gluts threaten cash flow and distributions.

The company relies heavily on the cyclical global semiconductor ecosystem and a limited number of major customers. International sales and complex manufacturing drive significant exposure to foreign, operational, and regulatory risks. Capital structure features a substantial debt load of $4.0 billion alongside $3.9 billion in goodwill.

Single-tenant triple-net retail real estate business faces risks from tenant defaults, geographic concentration, high leverage of $2.1 billion, and strict REIT compliance rules.

Regulation and cost recovery dominate Exelon’s risks, affecting utility rates, infrastructure investment, environmental compliance, and energy policy.

Graphic Packaging faces substantial risks from raw material and energy cost inflation, debt obligations, and product substitution threats. Global manufacturing operations expose the company to foreign exchange fluctuations, geopolitical conflicts, and facility disruptions.

HubSpot faces heavy competition from established software vendors and evolving AI technologies that could render its platform obsolete.

China’s List of Unreliable Entities designation threatens Illumina’s Chinese revenue and operations.